-
Autor
Coulie, Pierre G 2 Herrmann, Martin 2 Multhoff, Gabriele 2 Acs, Andreas 1 Adam, Dieter 1 Adam-Klages, Sabine 1 Agace, William W 1 Aghaeepour, Nima 1 Agostinis, Patrizia 1 Akdis, Mübeccel 1 Allez, Matthieu 1 Almeida, Larissa Nogueira 1 Alvisi, Giorgia 1 Anderson, Graham 1 Andrä, Immanuel 1 Annunziato, Francesco 1 Anselmo, Achille 1 Apetoh, Lionel 1 Bacher, Petra 1 Baert, Thais 1
-
Pracoviště
Abramson Cancer Center Flow Cytometry... 1 Alicante Institute for Health and Bio... 1 AsedaSciences West Lafayette IN USA 1 A·P·E Applied Physics and Electronics... 1 BC Children's Hospital Research Insti... 1 BCRT Flow Cytometry Lab Berlin Brande... 1 BD Biosciences San Jose CA USA 1 BD Life Sciences Ashland OR USA 1 BD Life Sciences San Diego CA USA 1 BIH Center for Regenerative Therapies... 1 Barts and The London School of Medici... 1 Beckman Coulter Inc Miami FL USA 1 Berlin Institute of Health partner si... 1 Bindley Biosciences Center Purdue Uni... 1 BioTechMed Graz Graz Austria 1 Biophysics R and D Engineering Milten... 1 Biotherapy and Vaccine Unit Institut ... 1 Burnet Institute AMREP Flow Cytometry... 1 Cancer Gene Therapy Group Transplanta... 1 Cancer Immunology Research Genentech ... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Autor
Coulie, Pierre G 2 Herrmann, Martin 2 Multhoff, Gabriele 2 Acs, Andreas 1 Adam, Dieter 1 Adam-Klages, Sabine 1 Agace, William W 1 Aghaeepour, Nima 1 Agostinis, Patrizia 1 Akdis, Mübeccel 1 Allez, Matthieu 1 Almeida, Larissa Nogueira 1 Alvisi, Giorgia 1 Anderson, Graham 1 Andrä, Immanuel 1 Annunziato, Francesco 1 Anselmo, Achille 1 Apetoh, Lionel 1 Bacher, Petra 1 Baert, Thais 1
-
Pracoviště
Abramson Cancer Center Flow Cytometry... 1 Alicante Institute for Health and Bio... 1 AsedaSciences West Lafayette IN USA 1 A·P·E Applied Physics and Electronics... 1 BC Children's Hospital Research Insti... 1 BCRT Flow Cytometry Lab Berlin Brande... 1 BD Biosciences San Jose CA USA 1 BD Life Sciences Ashland OR USA 1 BD Life Sciences San Diego CA USA 1 BIH Center for Regenerative Therapies... 1 Barts and The London School of Medici... 1 Beckman Coulter Inc Miami FL USA 1 Berlin Institute of Health partner si... 1 Bindley Biosciences Center Purdue Uni... 1 BioTechMed Graz Graz Austria 1 Biophysics R and D Engineering Milten... 1 Biotherapy and Vaccine Unit Institut ... 1 Burnet Institute AMREP Flow Cytometry... 1 Cancer Gene Therapy Group Transplanta... 1 Cancer Immunology Research Genentech ... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
Wiley Free Content od 1998 do Před 1 rokem
PubMed
31633216
DOI
10.1002/eji.201970107
Knihovny.cz E-zdroje
These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry enabling immunologists to avoid the common errors that often undermine immunological data. Notably, there are comprehensive sections of all major immune cell types with helpful Tables detailing phenotypes in murine and human cells. The latest flow cytometry techniques and applications are also described, featuring examples of the data that can be generated and, importantly, how the data can be analysed. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid, all written and peer-reviewed by leading experts in the field, making this an essential research companion.
- Garg, Abhishek D
-
Galluzzi, Lorenzo
Autor Galluzzi, Lorenzo Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris , France U1138, INSERM , Paris , France Université Paris Descartes, Sorbonne Paris Cité , Paris , France Université Pierre et Marie Curie , Paris , France Gustave Roussy Comprehensive Cancer Institute , Villejuif , France
- Apetoh, Lionel
- Baert, Thais
- Birge, Raymond B
-
Bravo-San Pedro, José Manuel
Autor Bravo-San Pedro, José Manuel Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris , France U1138, INSERM , Paris , France Université Paris Descartes, Sorbonne Paris Cité , Paris , France Université Pierre et Marie Curie , Paris , France Gustave Roussy Comprehensive Cancer Institute , Villejuif , France
- Breckpot, Karine
- Brough, David
- Chaurio, Ricardo
- Cirone, Mara
Free Medical Journals od 2010
PubMed Central od 2010
Europe PubMed Central od 2010
Open Access Digital Library od 2010-01-01
Open Access Digital Library od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources od 2010
PubMed
26635802
DOI
10.3389/fimmu.2015.00588
Knihovny.cz E-zdroje
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by cells succumbing to immunogenic cell death (ICD) favors the establishment of a productive interface with the immune system. This results in the elicitation of tumor-targeting immune responses associated with the elimination of residual, treatment-resistant cancer cells, as well as with the establishment of immunological memory. Although ICD has been characterized with increased precision since its discovery, several questions remain to be addressed. Here, we summarize and tabulate the main molecular, immunological, preclinical, and clinical aspects of ICD, in an attempt to capture the essence of this phenomenon, and identify future challenges for this rapidly expanding field of investigation.
- Publikační typ
- časopisecké články MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.